US/UK/Canada

Share

Contacts

  • Dag Bergheim Pettersen

    CEO


    Hulda Mellgrens gata 5 421 32 Västra Frölunda Sweden
    +46 (0) 31 771 71 50
    http://www.zinzino.com
    • Pick a time period -
    Tags ( Active)

    Zinzino AB (publ.): 250 International chefs and sommeliers recognize Zinzino’s BalanceOil+ with 2026 Superior Taste Award

    Award-winning omega-3 supplement earns international recognition for taste in one of the world's most respected blind sensory evaluations   More than 250 internationally renowned chefs and sommeliers have evaluated thousands of products from over 100 countries in one of the world's most respected blind tasting competitions. Among the recipients of the 2026 Superior Taste Award is BalanceOil+ Orange Lemon Mint, Zinzino's flagship omega-3 supplement.   Presented by the International Taste Institute in Brussels, the Superior Taste Award is widely regarded as one of the food and

    ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT MAY 2026

    Zinzino group revenue increased with a total of 14 %, compared with the previous year.   The revenue in May for Zinzino's sales markets increased by 14 % and amounted to SEK 312.2 (273.7) million. Faun Pharma's external sales amounted to SEK 3.9 (3.9) million. Overall, the Group increased revenues by 14 % to SEK 316.1 (277.6) million compared with the previous year. Accumulated revenue for January – May 2026 increased by 23 % to SEK 1,545.9 (1,254.0) million.   Revenues were distributed as follows: Regions,MSEK 26-May 25-May Change YTD 2026 YTD 2025 Change

    ZINZINO AB (PUBL.): ANNOUNCEMENT FROM THE ANNUAL GENERAL MEETING

    Zinzino AB (publ.) held its Annual General Meeting today, June 2, 2026, at which the following resolutions were adopted:   · To adopt the income statements and balance sheets for the parent company and the Group, · To distribute SEK 6 per share for the 2025 fiscal year and to carry forward the remaining portion of retained earnings, · To discharge the Board of Directors and the CEO from liability, · To elect Hans Jacobsson as Chairman of the Board and Staffan Hillberg, Pierre Mårtensson, and Ingela Nordenhav as the other Board members,  · That Board fees shall total SEK

    ZINZINO AB (PUBL.): INTERIM REPORT Q1 2026

    Strong growth and increased profitability   Revenue for the first quarter of 2026 amounted to SEK 922.1 (723.7) million, representing 27% (59%) growth compared to the corresponding period last year. In local currencies, revenue for the first quarter increased by 37% (60%) compared to the same period last year. EBITDA rose to SEK 142.3 (78.8) million after the EBITDA margin increased to 15.4% (10.9%). The improved EBITDA margin compared to the corresponding period last year was primarily attributable to stronger gross profit and economies of scale, despite the fact that Zinzino

    ZINZINO AB (PUBL.): SHARE SUBSCRIPTION DUE TO WARRANTS

    In the option program, Zinzino's general meeting resolved on 31 May 2022, 50,315 B shares have been subscribed (series 2022/2027:1). The price per share amounted to SEK 56 and in total Zinzino's equity was raised SEK 2,817,640.   In the option program, Zinzino's general meeting resolved on 31 May 2022, 15,000 B shares have been subscribed (series 2022/2027:2). The price per share amounted to SEK 56 and in total Zinzino's equity was raised SEK 840,000.   In the option program, Zinzino's general meeting resolved on 31 May 2023, 145,000 B shares have been subscribed.

    ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT APRIL 2026

    Zinzino group revenue increased with a total of 21 %, compared with the previous year.   The revenue in April for Zinzino's sales markets increased by 22 % and amounted to SEK 300.8 (246.6) million. Faun Pharma's external sales decreased and amounted to SEK 4.6 (6.1) million. Overall, the Group increased revenues by 21 % to SEK 305.4 (252.7) million compared with the previous year. Accumulated revenue for January – April 2026 increased by 26 % to SEK 1,227.5 (976.3) million. Revenues were distributed as follows: Regions, MSEK 26-Apr 25-Apr Change YTD 2026 YTD 2025

    ZINZINO AB (PUBL.): NOTICE OF THE ANNUAL GENERAL MEETING OF ZINZINO AB ON JUNE 2, 2026

    NOTICE OF THE ANNUAL GENERAL MEETING OF ZINZINO AB ON JUNE 2, 2026 The shareholders of Zinzino AB (publ) are hereby invited to the Annual General Meeting on Tuesday, June 2, 2026 at 9:30 a.m. at the company’s offices at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 9:15 a.m. The company intends to webcast the meeting to enable remote participation. RIGHT TO PARTICIPATE IN THE ANNUAL GENERAL MEETING Shareholders wishing to participate in the Annual General Meeting must i. be listed in the share register maintained by Euroclear Sweden AB as of Monday, May 25,

    ZINZINO AB (PUBL.): SHARE SUBSCRIPTION THROUGH A DIRECTED SET-OFF ISSUE

    Based on the authorization granted by the Annual General Meeting on May 28, 2025, the Board of Directors of the Company has resolved on the following directed share issue by way of set-off:   According to the resolution, 40,935 new Zinzino B shares have been issued by way of set-off of claims against Xion International Group. The transaction is linked to the previously communicated acquisition of Xion International Group on November 11, 2025.      Through the directed share issue, the number of B shares in the company increases by a total of 40,935 to a total of 33,562,509. The

    ZINZINO AB (PUBL.): ANNUAL REPORT 2025

    Zinzino AB (publ.) announces that the company's annual report for 2025 is now published on the company's website zinzino.com.   The 2026 Annual General Meeting will be held at the company's premises at Hulda Mellgrens gata 5 in Västra Frölunda on June 2. The nomination committee's proposals for board members, the board's remuneration and auditors are presented in the notice to the annual general meeting. For further information about the annual general meeting, refer to the company's website zinzino.com.         Link to the report: https://www.zinzino.com/site/gb/en-gb/

    Zinzino Wins Prestigious DSN Bravo Award and Achieves Top 20 Global Ranking

    Zinzino Operations AB (publ.), a global leader in test-based, personalized nutrition, today announces that the company has been honored with a prestigious Bravo Award by Direct Selling News (DSN), one of the most respected voices in the global direct selling industry. The DSN Bravo Awards recognize outstanding achievement and excellence across key areas, including growth, leadership, innovation, and industry impact. Widely regarded as one of the highest honors in direct selling, the awards recognize companies that set new performance benchmarks and advance the industry. In addition to

    ZINZINO AB (PUBL.): ANNA FRICK RESIGNS FROM THE BOARD OF ZINZINO

    Anna Frick has decided to leave the board of Zinzino AB (publ.). Her departure is for personal reasons.   Anna Frick has requested to resign from the Board of Directors of Zinzino AB (publ.) for personal reasons. Anna Frick was elected to the Board on May 20, 2021. Following her resignation, the Board consists of Chairman Hans Jacobsson and Board members Staffan Hillberg, Ingela Nordenhav, and Pierre Mårtensson.                       For more information: Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com 

    ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q1 2026

    Zinzino group revenue increased with a total of 26 % in Q1 compared with the previous year.   The revenue in March for Zinzino's sales markets increased by 29% and amounted to SEK 342.2 (265.8) million. Faun Pharma's external sales decreased and amounted to SEK 6.6 (7.1) million. Overall, the Group increased revenues by 28% to SEK 348.8 (272.9) million compared with the previous year. The group revenue increased with 26 % for Q1 2026 compared with the first quarter last year and amounted to SEK 915.4 (723.7) million. Revenues were distributed as follows: Regions, 26-mar 25-

    ZINZINO AB (PUBL): Share subscription due to directed new share issues

    Based on the authorization granted by the Annual General Meeting on May 28, 2025, the Board of Directors of the Company has resolved on two directed share issues by way of set-off.   According to the resolution, 401,965 new Zinzino B shares have been issued by way of set-off of claims against S&M Nano-Biotechnology S.A DE C.V. The transaction is linked to the previously communicated acquisition of assets and subsidiaries of Sanki on November 8, 2025.   According to the resolution, 69, 621 new Zinzino B shares have been issued by way of set-off of claims against Bodē Pro. The

    ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT FEBRUARY 2026

    Zinzino group revenue increased with a total of 32 %, compared with the previous year.   The revenue in February for Zinzino's sales markets increased by 32 % and amounted to SEK 281.1 (212.7) million. Faun Pharma's external sales increased and amounted to SEK 5.2 (4.2) million. Overall, the Group increased revenues by 32 % to SEK 286.3 (216.9) million compared with the previous year. Accumulated revenue for January – February 2026 increased by 26 % to SEK 568.6 (450.8) million.   Revenues were distributed as follows:   Regions,MSEK 26-Feb 25-Feb Change YTD

    ZINZINO AB (PUBL.): YEAR-END REPORT 2025

    INCREASES DIVIDEND BY 50% TO SEK 6 AFTER HIGH GROWTH AND SIGNIFICANT IMPROVEMENT IN PROFITABILITY Revenue for the fourth quarter of 2025 amounted to SEK 1,035.3 (713.5) million, corresponding to 45% (35%) growth compared with the same period last year. In local currencies, revenue for the fourth quarter increased by 52% compared with the corresponding period last year. EBITDA rose to SEK 175.2 (72.9) million after the EBITDA margin increased to 16.9% (10.2%). The improved EBITDA margin compared to the corresponding period last year was mainly due to stronger gross profit and increased

    ZINZINO AB (PUBL.): ZINZINO ANNOUNCES PERU AS NEXT STEP IN ITS GLOBAL EXPANSION

    Zinzino is pleased to announce that it will launch its operations in Peru on February 10th, 2026. Zinzino continues to strengthen its presence in Latin America with the launch of operations in Peru, which has generated monthly sales of approximately SEK 1.5 million through the company’s global web shop. The expansion builds on the company’s established success in existing Latin American markets, creating strong cross-border synergies for both partners and customers. Peru offers attractive conditions for direct selling business, with a growing entrepreneurial culture and increasing

    ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT JANUARY 2026

    Zinzino group revenue increased with a total of 20 %, compared with the previous year.   The revenue in January for Zinzino's sales markets increased by 20% and amounted to SEK 274.1 (229.2) million. Faun Pharma's external sales increased and amounted to SEK 7.1 (4.7) million. Overall, the Group increased revenues by 20 % to SEK 281.2 (233.9) million compared with the previous year. Revenues were distributed as follows: Regions, mSEK 26-Jan 25-Jan ChangeThe Nordics 27.3 25.9 5%Central Europe 90.1 69.4 30%East Europe 29.4 34.2

    ZINZINO AB (PUBL.): Zinzino announces merger of It Works! into the Zinzino family of businesses for increased distribution power in North America and Europe

    Zinzino has today entered into an agreement, and simultaneously closed, to combine with the US-based direct sales company It Works! In an all-share transaction. Through the merger, Zinzino acquired the operational assets of It Works!’ US business, including inventory, distributor agreements, customer agreements, and IP rights, as well as 100% of the shares in It Works! Marketing International UC, an Irish unlimited company, and its wholly owned subsidiaries.   The fixed purchase price amounts to USD 30 million (the “Purchase Price”) which has been paid by Zinzino through a directed

    ZINZINO AB (PUBL): PRELIMINARY SALES REPORT 2025

    Zinzino group revenue increased 46% in Q4 and total revenue for the full year 2025 increased 51%, compared with the previous year.   The revenue in December for Zinzino's sales markets increased by 35 % and amounted to SEK 334.4 (246.9) million. Faun Pharma's external sales decreased and amounted to SEK 2.9 (5.8) million. Overall, the Group increased revenues by 33 % to SEK 337.3 (252.7) million compared with the previous year. Revenue in Zinzino's sales markets increased by 50 % in the fourth quarter of 2025 compared with the same period last year and amounted to SEK 1,032.3 (690.

    ZINZINO AB (PUBL.): Zinzino AB changes Certified Adviser to Tapper Partners AB

    Zinzino AB announces today that the company is changing its Certified Adviser to Tapper Partners AB.   Zinzino AB has entered into an agreement with Tapper Partners AB regarding the role of Certified Adviser. Tapper Partners AB will assume the role of Certified Adviser on December 8, 2025. Until then, DNB Carnegie Investment Bank AB will continue to act as the company's Certified Adviser.                     For more information: Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com  Fredrik Nielsen CFO

    ZINZINO AB (PUBL.): Preliminary sales report November 2025

    Zinzino group revenue increased with a total of 45 %, compared with the previous year.   The revenue in November for Zinzino's sales markets increased by 49 % and amounted to SEK 375.0 (251.8) million. Faun Pharma's external sales decreased and amounted to SEK 4.3 (10.1) million. Overall, the Group increased revenues by 45 % to SEK 379.3 (261.9) million compared with the previous year. Accumulated revenue for January – November 2025 increased by 54 % to SEK 3,007.5 (1,955.1) million.   Revenues were distributed as follows: Regions,MSEK 25-Nov 24-Nov Change YTD

    ZINZINO AB (PUBL.): Share subscription due to warrants

    In the option program Zinzino's general meeting resolved on 31 May 2022, 12,000 B shares have been subscribed (series 2022/2027:1). The price per share amounted to SEK 56 and in total Zinzino's equity was raised SEK 672,000.   In the option program Zinzino's general meeting resolved on 31 May 2023, 30,000 B shares have been subscribed. The price per share amounted to SEK 63 and in total Zinzino's equity was raised SEK 1,890,000.   The total number of B shares increased by 42,000 to 31,206,148. The total number of shares after the increase was 36,319,540. The dilution amounted to

    Zinzino AB (publ.): Interim Report for the third quarter of 2025

    Strong sales growth and increased profit margins drive profitability upwards   Revenue for the third quarter of 2025 amounted to SEK 784.1 (532.8) million, corresponding to 47% (22%) growth compared with the same period last year. In local currencies, revenue for the third quarter increased by 53% compared with the corresponding period last year. EBITDA increased to SEK 109.7 (63.0) million after the EBITDA margin increased to 14.0% (11.8%). The improved EBITDA margin compared to the corresponding period last year was mainly due to stronger gross profit and increased synergies,

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media